BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21790895)

  • 41. Cyclin D2 dysregulation by chromosomal translocations to TCR loci in T-cell acute lymphoblastic leukemias.
    Clappier E; Cuccuini W; Cayuela JM; Vecchione D; Baruchel A; Dombret H; Sigaux F; Soulier J
    Leukemia; 2006 Jan; 20(1):82-6. PubMed ID: 16270038
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin.
    Decker T; Hipp S; Ringshausen I; Bogner C; Oelsner M; Schneller F; Peschel C
    Blood; 2003 Jan; 101(1):278-85. PubMed ID: 12393642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cyclin D expression in chronic lymphocytic leukemia.
    Paul JT; Henson ES; Mai S; Mushinski FJ; Cheang M; Gibson SB; Johnston JB
    Leuk Lymphoma; 2005 Sep; 46(9):1275-85. PubMed ID: 16109604
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cell cycle phase distribution analysis in chronic lymphocytic leukaemia: a significant number of cells reside in early G1-phase.
    Obermann EC; Went P; Tzankov A; Pileri SA; Hofstaedter F; Marienhagen J; Stoehr R; Dirnhofer S
    J Clin Pathol; 2007 Jul; 60(7):794-7. PubMed ID: 16950856
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High p27 protein levels in chronic lymphocytic leukemia are associated to low Myc and Skp2 expression, confer resistance to apoptosis and antagonize Myc effects on cell cycle.
    Caraballo JM; Acosta JC; Cortés MA; Albajar M; Gómez-Casares MT; Batlle-López A; Cuadrado MA; Onaindia A; Bretones G; Llorca J; Piris MA; Colomer D; León J
    Oncotarget; 2014 Jul; 5(13):4694-708. PubMed ID: 25051361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. EZH2 is upregulated in the proliferation centers of CLL/SLL lymph nodes.
    Szurián K; Csala I; Marosvári D; Rajnai H; Dezső K; Bödör C; Piurkó V; Matolcsy A; Reiniger L
    Exp Mol Pathol; 2018 Oct; 105(2):161-165. PubMed ID: 30031020
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quantitative analysis of Cyclin D1 and CD23 expression in mantle cell lymphoma and B-chronic lymphocytic leukemia.
    Koiso H; Tsukamoto N; Miyawaki S; Shinonome S; Nojima Y; Karasawa M
    Leuk Res; 2002 Sep; 26(9):809-15. PubMed ID: 12127555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chronic lymphocytic leukemia/small lymphocytic lymphoma with cyclin D1 positive proliferation centers do not have CCND1 translocations or gains and lack SOX11 expression.
    Gradowski JF; Sargent RL; Craig FE; Cieply K; Fuhrer K; Sherer C; Swerdlow SH
    Am J Clin Pathol; 2012 Jul; 138(1):132-9. PubMed ID: 22706868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mechanism for IL-15-Driven B Cell Chronic Lymphocytic Leukemia Cycling: Roles for AKT and STAT5 in Modulating Cyclin D2 and DNA Damage Response Proteins.
    Gupta R; Li W; Yan XJ; Barrientos J; Kolitz JE; Allen SL; Rai K; Chiorazzi N; Mongini PKA
    J Immunol; 2019 May; 202(10):2924-2944. PubMed ID: 30988120
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression and regulation of COP1 in chronic lymphocytic leukemia cells for promotion of cell proliferation and tumorigenicity.
    Fu C; Gong Y; Shi X; Shi H; Wan Y; Wu Q; Xu K
    Oncol Rep; 2016 Mar; 35(3):1493-500. PubMed ID: 26717976
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proliferation centers in chronic lymphocytic leukemia: the niche where NF-kappaB activation takes place.
    Herreros B; Rodríguez-Pinilla SM; Pajares R; Martínez-Gónzalez MA; Ramos R; Munoz I; Montes-Moreno S; Lozano M; Sánchez-Verde L; Roncador G; Sánchez-Beato M; de Otazu RD; Pérez-Guillermo M; Mestre MJ; Bellas C; Piris MA
    Leukemia; 2010 Apr; 24(4):872-6. PubMed ID: 20072150
    [No Abstract]   [Full Text] [Related]  

  • 52. CTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemia.
    Ciszak L; Frydecka I; Wolowiec D; Szteblich A; Kosmaczewska A
    Clin Exp Med; 2016 Aug; 16(3):317-32. PubMed ID: 26003188
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional loss of IκBε leads to NF-κB deregulation in aggressive chronic lymphocytic leukemia.
    Mansouri L; Sutton LA; Ljungström V; Bondza S; Arngården L; Bhoi S; Larsson J; Cortese D; Kalushkova A; Plevova K; Young E; Gunnarsson R; Falk-Sörqvist E; Lönn P; Muggen AF; Yan XJ; Sander B; Enblad G; Smedby KE; Juliusson G; Belessi C; Rung J; Chiorazzi N; Strefford JC; Langerak AW; Pospisilova S; Davi F; Hellström M; Jernberg-Wiklund H; Ghia P; Söderberg O; Stamatopoulos K; Nilsson M; Rosenquist R
    J Exp Med; 2015 Jun; 212(6):833-43. PubMed ID: 25987724
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EBV-negative Hodgkin lymphoma in ZAP-70-positive B-cell lymphocytic leukemia patient.
    Cerny J; Wang S; Miron P; Hutchinson L; Brettler D
    Ann Hematol; 2009 May; 88(5):495-7. PubMed ID: 18843488
    [No Abstract]   [Full Text] [Related]  

  • 55. Expression and regulation of CacyBP/SIP in chronic lymphocytic leukemia cell balances of cell proliferation with apoptosis.
    Fu C; Wan Y; Shi H; Gong Y; Wu Q; Yao Y; Niu M; Li Z; Xu K
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):741-8. PubMed ID: 26603518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ILK Induction in Lymphoid Organs by a TNFα-NF-κB-Regulated Pathway Promotes the Development of Chronic Lymphocytic Leukemia.
    Krenn PW; Hofbauer SW; Pucher S; Hutterer E; Hinterseer E; Denk U; Asslaber D; Ganghammer S; Sternberg C; Neureiter D; Aberger F; Wickström SA; Egle A; Greil R; Hartmann TN
    Cancer Res; 2016 Apr; 76(8):2186-96. PubMed ID: 26837762
    [TBL] [Abstract][Full Text] [Related]  

  • 57. De novo CD5-positive diffuse large B-cell lymphomas show high specificity for cyclin D2 expression.
    Igawa T; Sato Y; Takata K; Iwaki N; Tanaka T; Asano N; Maeda Y; Orita Y; Nakamura N; Nakamura S; Yoshino T
    Diagn Pathol; 2013 May; 8():81. PubMed ID: 23675804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of nuclear factor kappa B activation in early-stage chronic lymphocytic leukemia by omega-3 fatty acids.
    Fahrmann JF; Ballester OF; Ballester G; Witte TR; Salazar AJ; Kordusky B; Cowen KG; Ion G; Primerano DA; Boskovic G; Denvir J; Hardman WE
    Cancer Invest; 2013 Jan; 31(1):24-38. PubMed ID: 23193970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thalidomide regulation of NF-κB proteins limits Tregs activity in chronic lymphocytic leukemia.
    Skórka K; Bhattacharya N; Własiuk P; Kowal M; Mertens D; Dmoszyńska A; Giannopoulos K
    Adv Clin Exp Med; 2014; 23(1):25-32. PubMed ID: 24596000
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Proliferation centres of chronic lymphocytic leukaemia/small lymphocytic lymphoma have enhanced expression of MYC protein, which does not result from rearrangement or gain of the MYC gene.
    Gibson SE; Leeman-Neill RJ; Jain S; Piao W; Cieply KM; Swerdlow SH
    Br J Haematol; 2016 Oct; 175(1):173-5. PubMed ID: 26568397
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.